Dr Reddys Laboratories announced its third quarter 2025 results on January 25, 2025: profit increased by 2.38% year-on-year, with profit of 1,413.7 billion rupees and revenue of 83,812 million rupees.

2025-01-25 11:51:00 :

Dr Reddys Laboratories third quarter 2025 results: Dr Reddys Laboratories announced its third quarter results on January 23, 2025, with revenue increasing by 15.81% year-on-year. Profit increased by 2.38% year-on-year, and profit data reached $Revenue peaked at Rs 1,413.7 crore. $8381.2 Crores.

Compared with the previous quarter, revenue increased by 4.27% and profit increased by 12.58%. However, selling, general and administrative expenses increased by 0.7% month-on-month and 16.53% year-on-year.

This quarter’s operating income increased by 7.27% month-on-month and 9.21% year-on-year. Earnings per share (EPS) is $In the third quarter, it was 16.94, a year-on-year increase of 1.68%.

Dr Reddys Laboratories reported a return of -1.02% last week, a return of -5.93% over the past six months, and a return of -7.14% year-to-date.

Currently, Dr. Reddy’s Laboratories has a market capitalization of $1,07,422.6 billion rupees, a 52-week high $1421.49 and lowest price $1120.

Of the 35 analysts covering the company as of January 25, 2025, 5 have a Strong Sell rating, 8 have a Sell rating, 9 have a Hold rating, 7 have a Buy rating, and 6 have a Buy rating. Named with a Strong Buy rating. As of now, the consensus recommendation is Hold.

Dr Reddy’s Laboratories Financial Status

period	Q3 (FY2025)	Q2 (FY25)	month-on-month growth	Q3 (FY2024)	year-on-year growth
total revenue	8381.2	8038.2	+4.27%	7236.8	+15.81%
Total Selling/General/Administrative Expenses	3527.1	3502.6	+0.7%	3026.7	+16.53%
Depreciation/Amortization	471.4	Chapter 397	+18.74%	373.5	+26.21%
total operating expenses	6579.6	6358.7	+3.47%	5587.2	+17.76%
operating income	1801.6	1679.5	+7.27%	1649.6	+9.21%
net income before tax	1874.3	1917.4	-2.25%	1829.1	+2.47%
net income	1413.7	1255.7	+12.58%	1380.9	+2.38%
Diluted normalized earnings per share	16.94	15.85	+6.88%	16.66	+1.68%

ALSO READ Company News today updated in real time, January 25, 2025: "False and misleading": Adiden Group denies the cancellation of Sri Lanka's $ 440 million power purchase transaction; this is why why is why why is why?

Get the latest updates on quarterly results with our results calendar

Disclaimer: This is an AI-generated live blog and has not been edited by LiveMint staff.